Ceftrivin TZ 1.125 Injection
Marketer
Vintek Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceftrivin TZ 1.125 Injection
Ceftrivin TZ 1.125 Injection, a dual-action medication, combats a range of bacterial infections by hindering microbial proliferation. Administration must be overseen by a qualified medical professional. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment can compromise its effectiveness. Complete the full course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Worsening side effects warrant immediate medical consultation. Seek immediate emergency care for allergic reactions (skin rashes, itching, swelling, respiratory distress). Inform your doctor of all current medications, and pregnant or nursing individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, proper nutrition, and hydration are essential for optimal recovery. Your doctor may order lab tests to monitor treatment efficacy.
Uses of Ceftrivin TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Ceftrivin TZ 1.125 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceftrivin TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftrivin TZ 1.125 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Ceftrivin TZ 1.125 Injection works:
Ceftrivin TZ 1.125 Injection unites Ceftriaxone, a crucial antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactum counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Combining Ceftrivin TZ 1.125 Injection with alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Ceftrivin TZ 1.125 Injection during pregnancy is typically deemed safe. Preclinical trials using animal models revealed minimal or no harmful consequences to the fetus; nonetheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administering Ceftrivin TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Ceftrivin TZ 1.125 Injection may induce drowsiness, blurred vision, or dizziness. Driving is inadvisable if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftrivin TZ 1.125 Injection use in individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Ceftrivin TZ 1.125 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Ceftrivin TZ 1.125 Injection is usually unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ceftrivin TZ 1.125 Injection :
Should you forget a scheduled dose of Ceftrivin TZ 1.125 Injection, seek medical advice.
Facts to Know About Ceftrivin TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |



